- Home
- CRGX vs SLQT Comparison
CRGX vs SLQT Comparison
Compare CRGX & SLQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- SLQT
- Stock Information
- Founded
- CRGX 2021
- SLQT 1999
- Country
- CRGX United States
- SLQT United States
- Employees
- CRGX N/A
- SLQT N/A
- Industry
- CRGX
- SLQT Specialty Insurers
- Sector
- CRGX
- SLQT Finance
- Exchange
- CRGX Nasdaq
- SLQT Nasdaq
- Market Cap
- CRGX 621.4M
- SLQT 682.6M
- IPO Year
- CRGX 2023
- SLQT 2020
- Fundamental
- Price
- CRGX $12.00
- SLQT $4.17
- Analyst Decision
- CRGX Strong Buy
- SLQT Hold
- Analyst Count
- CRGX 6
- SLQT 1
- Target Price
- CRGX $31.80
- SLQT $4.00
- AVG Volume (30 Days)
- CRGX 280.5K
- SLQT 1.4M
- Earning Date
- CRGX 11-12-2024
- SLQT 02-05-2025
- Dividend Yield
- CRGX N/A
- SLQT N/A
- EPS Growth
- CRGX N/A
- SLQT N/A
- EPS
- CRGX N/A
- SLQT N/A
- Revenue
- CRGX N/A
- SLQT $1,381,309,000.00
- Revenue This Year
- CRGX N/A
- SLQT $12.73
- Revenue Next Year
- CRGX N/A
- SLQT $14.03
- P/E Ratio
- CRGX N/A
- SLQT N/A
- Revenue Growth
- CRGX N/A
- SLQT 28.72
- 52 Week Low
- CRGX $10.91
- SLQT $1.03
- 52 Week High
- CRGX $33.92
- SLQT $4.55
- Technical
- Relative Strength Index (RSI)
- CRGX 37.06
- SLQT 66.41
- Support Level
- CRGX $10.91
- SLQT $3.58
- Resistance Level
- CRGX $15.75
- SLQT $4.10
- Average True Range (ATR)
- CRGX 1.19
- SLQT 0.33
- MACD
- CRGX -0.16
- SLQT -0.01
- Stochastic Oscillator
- CRGX 22.15
- SLQT 69.20
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.